A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Recruiting now · Phase 1
Conditions studied: Metastatic Castration-resistant Prostate Cancer
In brief
This study will assess the safety and tolerability of valemetostat in combination with darolutamide in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC).
Key facts
- Study ID
- NCT07244341
- Run by
- Daiichi Sankyo
- People needed
- 60
- Starts
- 2025-12-03
- Expected to finish
- 2029-11-30
- Last updated by the study team
- 2026-05-15
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- University of California San Diego Moores Cancer Center — La Jolla, California, United States (enrolling)
- Beth Isreal Deaconess Medical Center — Boston, Massachusetts, United States (enrolling)
- Dana Farber Cancer Institute — Newton, Massachusetts, United States (enrolling)
- Cancer & Hematology Center — Grand Rapids, Michigan, United States (enrolling)
- Northwell Health Cancer Institute (START NY) — Lake Success, New York, United States (enrolling)
- Carolina Urologic Research Center — Myrtle Beach, South Carolina, United States (enrolling)
- NEXT Oncology — San Antonio, Texas, United States (enrolling)
- Virginia Cancer Specialists (NEXT Virginia) — Fairfax, Virginia, United States (enrolling)
- Medical College Of Wisconsin — Milwaukee, Wisconsin, United States (enrolling)
- Sun Yatsen University Cancer Center — Guangzhou, China (enrolling)
- Fudan University Shanghai Cancer Center - Xuhui District — Shanghai, China (enrolling)
- Fudan University Shanghai Cancer Center — Shanghai, China (enrolling)
- Shanghai General Hospital — Shanghai, China (enrolling)
- The First Affiliated Hospital of Wenzhou Medical University — Wenzhou, China (enrolling)
- Mater Misericordiae University Hospital — Dublin, Ireland (enrolling)
- National Cancer Center Hospital East — Kashiwa-shi, Japan (enrolling)
- Kobe City Med Cen Gen Hosp. — Kobe, Japan (enrolling)
- Cancer Institute Hospital of JFCR — Kōtoku, Japan (enrolling)
- Toho University Sakura Medical Center — Sakura-shi, Japan (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.